GoldenGolden
Advanced Search
Antiva Biosciences

Antiva Biosciences

Antiviral therapy

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

April 21, 2021
Antiva Biosciences appoints Clifford Samuel as Company's Board of Directors.
March 2017
Antiva Biosciences raises a $22,000,000 series C round from Brace Pharma Capital, Canaan Partners, NS Investment and Osage University Partners.

Funding rounds

Patents

Products

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Antiva Biosciences, Inc.
April 21, 2021
www.prnewswire.com:443
/PRNewswire/ -- Antiva Biosciences, a biopharmaceutical company developing novel, topical therapeutics for the treatment of pre-cancerous lesions caused by...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.